Anaren, Inc. (ANEN) Tops Q2 EPS by 2c; Guides Q3

Anaren, Inc. (NASDAQ: ANEN) reported Q2 EPS of $0.13, $0.02 better than the analyst estimate of $0.11. Revenue for the quarter came in at $35.74 million versus the consensus estimate of $36.94 million.

Anaren, Inc. sees Q3 2012 EPS of $0.11-$0.15, versus the consensus of $0.19. Anaren, Inc. sees Q3 2012 revenue of $34-$39 million, versus the consensus of $39.6 million.

For earnings history and earnings-related data on Anaren, Inc. (ANEN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Stardust Power (SDST) Tops Q2 EPS by 1c